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Sodium butyrate, which blocks the cell cycle of many cell types in the GI phase, strongly inhibits the 
synthesis of the transformation related, 53 kDa protein in 3T6 fibroblasts but much less so in SV 40 
transformed mouse cells. By several criteria, this effect of the fatty acid appears to be indirect; p 53 
synthesis takes place several hours after the butyrate-sensitive step in GI. The results are discussed in the 
light of a putative role of p 53 in growth control. 
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1. INTRODUCTION 
Sodium butyrate interferes with the cell cycle 
progression in many cell types. It generally causes 
an arrest in the G1 phase of the cell cycle and in 
some cell systems a concomitant induction of ter- 
minal differentiation [l-7]. 3T6 mouse fibroblasts 
are blocked by butyrate at a control point in G1 
several hours prior to the beginning of the S phase, 
and serum factors are required before and after the 
butyrate-sensitive step if cells are to progress into 
the S phase [8]. Low concentrations of cyclohex- 
imide have a similar effect on cell cycle progression 
and, interestingly, 3T6 or 3T3 fibroblasts are con- 
siderably more sensitive to these substances than 
are transformed cells [8-lo]. These data were inter- 
preted to indicate the requirement in mid Cl of the 
synthesis of (a) labile, rapidly turning-over pro- 
tein(s) which may become more stable (or more ex- 
tensively expressed) in transformed cells [9, lo]. 
One interesting candidate for such a protein is p 
53, which was first detected in SV 40 transformed 
cells, where it was shown to form a tight complex 
with SV 40 large T antigen [l l-131. It is assumed 
that the formation of this complex leads to 
stabilisation of p 53 in the cell cycle of SV 40 
transformed cells. Here we show that the synthesis 
of p 53 by 3T6 cells is strongly inhibited if sodium 
butyrate is added to the culture medium; in con- 
trast, synthesis of p 53, like cell cycle progression, 
in SV 40 transformed mouse kidney cells, is 
remarkable resistant o the fatty acid. 
2. MATERIALS AND METHODS 
3T6 cells and SV 40 transformed mouse kidney 
cells (SVMK) were grown as in [7,8]. Sodium 
butyrate treatment was carried out for 24 h at a 
final drug concentration of 7 mM. For im- 
munofluorescence, cells were washed twice with 
phosphate-buffered saline (PBS), fixed with cold 
acetone-methanol (7 : 3) and dried. Fixed cells were 
incubated with anti p 53 monoclonal antibody [ 141 
(PAb 122 from ATCC) followed by fluorescein- 
labelled goat anti-mouse immunoglobulin, ex- 
amined in a Zeiss fluorescence microscope and 
photographed. 
Labelling of cells with [35S]methionine was car- 
ried out by incubation for 3 h at 37°C with the 
radioactive amino acid (20-30 &i/ml methionine- 
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free medium containing 2% calf serum; 3 ml/10 
cm dish). Cells were then washed twice with PBS, 
scraped into 0.5 ml/dish of lysis buffer (600 mM 
NaCl, 50 mM Tris-HCl [pH 8.01, 0.5% NP40, 5 
mM EDTA, 0.2 mM/l PMSF) and fully disrupted 
by 3 min sonication in a sonicator bath. After 
removing the debris by 10 min centrifugation in an 
Eppendorf centrifuge, the extracts were incubated 
for 30 min at 0°C with 10~1 of p 53 antibody (PAb 
122) which was followed by 30 ~1 of a 1: 1 suspen- 
sion of protein A-Sepharose. Incubation at 4°C 
was continued overnight with gentle shaking. Pro- 
tein A-Sepharose was then collected by centrifuga- 
tion and washed 3 times with 500 ~1 each of 0.1 M 
Tris-HCl (pH 8.8), 1% 2-mercaptoethanol, 1% 
NP40, 0.5 M LiCl. The immunoprecipitates were 
finally eluted and dissociated with 500~1 of sample 
buffer for SDS gel electrophoresis [15] by heating 
for 10 min at 100°C. Protein A-Sepharose was 
removed by centrifugation and the supernatants 
were applied onto 12.5% SDS-polyacrylamide 
gels with 5% stacking gels. After electrophoresis 
the gels were fluorographed [16] and the 
autoradiogram scanned with a Helena Quick Scan. 
3. RESULTS AND DISCUSSION 
Using a monoclonal antibody (PAb 233) against 
mouse p 53 [ 141, the amount (determined by im- 
munofluorescence) and rate of synthesis (deter- 
mined by labelling with [3SS]methionine) of p 53 
in 3T6 cells are strongly inhibited by sodium 
butyrate (fig.l,2). In SV 40 transformed mouse 
cells, in contrast, p 53 is only slightly effected by 
the substance (fig.1) in agreement with the much 
higher resistance to butyrate of the cell cycle pro- 
gression of SV 40 transformed cells [8]. Following 
release of cells from the butyrate-induced Ci1 
block, 3T6 cells resume the synthesis of p 53 after 
a lag period of about 6 h (fig.2); cells enter the S 
phase a few hours later [8]. These results suggest 
that p 53 is synthesized in mid and late G1 only a 
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Fig.1. Immunofluorescence of p 53 in SV40 transformed cells (SVMK) and in 3T6 cells in the absence of butyrate or 
after 24 h treatment with 7 mM sodium butyrate. 
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Fig.2. Immunoprecipitation and electrophoresis of 35S- 
removal. The arrow indicates the position of p 53. 
labelled p 53. Labelling was for 3 h in each case. (a) Nor- 
mally grown 3T6 cells, (b) cells treated for 24 h and 
labelled in the presence of butyrate, (c) cells labelled 
from 0 to 3 h after release from the butyrate-induced 
block, (d) cells labelled from 3 to 6 h after butyrate 
removal, (e) cells labelled from 6 to 9 h after butyrate 
few hours before the S phase starts. Sodium 
butyrate may directly or indirectly interfere with p 
53 synthesis. The lag of several hours after 
butyrate removal which passes before p 53 syn- 
thesis begins argues against direct interference of 
the fatty acid with p 53 expression. This is sup- 
ported by the fact that 3 h pulse labelling carried 
out in the presence or absence of the fatty acid 
68- 
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Fig.3. Immunoprecipitation and electrophoresis of “S- 
labelled p 53. (a) Normally grown 3T6 cells labelled for 
and the peak areas of p 53 determined. 
3 h in the presence of 7 mM sodium butyrate (added at 
the same time as [35S]methionine), (b) cells incubated in 
the presence of butyrate for 3 h followed by 3 h labell- 
ing, (c) cells incubated in the presence of butyrate for 6 
h followed by 3 h labelling, (d) normally grown cells 
labelled for 3 h in the absence of butyrate, (e) same as 
(d) but followed by a 6 h chase with fresh, methionine- 
containing medium. For quantitation, gels were scanned 
results . identical incorporation of 
[35S]methidiine into p 53 (fig.3, cf. lanes a and d). 
If the labelling is carried out from 3-6 h or from 
6-9 h after addition of butyrate, radioactivity in p 
53 is reduced to 77 and 50070, respectively 
(fig.3b,c). This result again indicates that the syn- 
thesis of p 53 starts a few hours after the butyrate- 
sensitive step in the Gr phase of the cell cycle. It is 
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more likely therefore that sodium butyrate inhibits 
the production of other proteins in the cell cycle 
which then control the synthesis of p 53. This con- 
clusion is in line with the idea of the existence of 
a series of consecutive events which have to be 
passed by cells progressing towards the S phase 
[17]. The role of p 53 in this series of events is not 
yet known but our results support the idea [ 18,191 
that the protein is involved in cell cycle regulation. 
Sodium butyrate is one of several substances 
known to cause terminal differentiation in murine 
erythroleukemia cells, a process which is accom- 
panied by a cessation of cell growth. Interestingly, 
while this paper was in preparation two groups 
[20,21] reported that other inducers of differentia- 
tion, namely hexamethylenebisacetamide and 
dimethyl sulfoxide cause a decrease in p 53 syn- 
thesis in erythroleukemia cells concomitant with a 
commitment of these cells to terminal cell division. 
These results also implicate a role of p 53 in cell 
proliferation. Much evidence supporting this 
hypothesis came from studies which showed that a 
variety of transformed cells, including tumor cell 
lines induced by chemicals or DNA- and RNA- 
viruses, have elevated levels of this protein 
[ 11,22-251. The half-life of p 53 varies dramatical- 
ly in normal vs transformed cells: 20-60 min in 3T3 
cells but longer than 20 h in SV 40 transformed 
3T3 cells [26]. In pulse-chase experiments we 
found a half-life of about 6 h for p 53 in our 3T6 
cell line (fig.3d,e); this is considerably longer than 
that of the protein in 3T3 cells implying that 3T6 
cells in this aspect behave more like transformed 
ones which is in agreement with other properties of 
this cell line [9,10,27]. In confirmation of reports 
from other groups we also found that p 53 can 
hardly be detected in 3T3 cells by im- 
munofluorescence (not shown) while it is readily 
visible in 3T6 cells and much better in SV 40 
transformed mouse cells (fig.1). On the other 
hand, the growth rates of 3T3, 3T6 or SVMK cells 
are not nearly as variable as the concentration of 
immunologically reactive p 53 and studies in fact 
indicate that not all rapidly growing tumor cells ex- 
hibit high levels of the protein [28]. This discrepan- 
cy remains to be resolved before the role of p 53 in 
growth control can be understood. 
Using serum stimulated 3T3 cells, authors in [ 191 
showed that the microinjection of anti p 53 
monoclonal antibody into these cells partly in- 
hibited their transition into the S phase and fur- 
thermore that this inhibition was only effective if 
the antibody was injected up to 2 h after serum ad- 
dition. Accordingly, p 53 was considered by these 
authors to be an early Gr protein. Our ex- 
periments, on the contrary, suggest that the pro- 
tein is synthesized in the second half of Gr. An ex- 
planation for this difference is not available as yet, 
however more direct information on the cell cycle 
events in which p 53 is involved could perhaps be 
obtained by injecting the isolated protein into 
serum-starved or butyrate-blocked cells and by 
determining whether such cells thereby gain the 
ability to enter the S phase. Such experiments are 
in progress. 
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